EUVIMEDObjevte EUVIMED
Crossref

A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?

Basem M Mishriky iD, Doyle M Cummings, James R Powell

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3715 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, 2024. Written by Basem M Mishriky and 2 co-authors. Institution: Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA. Major MEDLINE topics: Sodium-Glucose Transporter 2 Inhibitors, Atrial Fibrillation, Diabetes Mellitus, Type 2, Symporters. Cited 1 times so far (Crossref); 18 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BMM has served on Advisory Board Panels for AstraZeneca and Bayer. DMC and JRP report no conflicts of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/dmrr.3715. The data that support the findings of this study are available from the corresponding author upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Subjects

MeSH terms (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsAtrial FibrillationDiabetes Mellitus, Type 2SymportersHeart FailureHumansRandomized Controlled Trials as TopicHypoglycemic AgentsGlucoseSodium

Author keywords

SGLT-2 inhibitorsatrial fibrillationcardiovascular outcome trialsheart failure trialsrenal outcome trials

Substances

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsSymportersGlucoseSodium

Authors and institutions

  • Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA.
  • Department of General Internal Medicine, Duke University Health System, Raleigh, USA.
  • Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
  • Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.

ORCID profiles: Basem M Mishriky

Cite

APA

Mishriky, B. M., Cummings, D. M., & Powell, J. R. (2024). A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3715

Vancouver

Mishriky BM, Cummings DM, Powell JR. A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3715

BibTeX
@article{Mishriky2024,
  author = {Mishriky, Basem M and Cummings, Doyle M and Powell, James R},
  title = {A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3715}
}
Start for free →